Why is it so hard to pay healthy medical research volunteers fairly? | STAT
How much would you have to be paid to risk a bout with a disease that most Americans associate with the Oregon Trail?| STAT
How much would you have to be paid to risk a bout with a disease that most Americans associate with the Oregon Trail?| STAT
“Good for Cigna!” or “insurers hold all the power”? Readers debate a recent STAT op-ed.| STAT
TrumpRx and a most-favored nation policy won’t lower prices for patients, writes the CEO and co-founder of I-MAK.| STAT
There’s a gray market in GLP-1s. It’s dangerous, but for people like this author, the risks feel worth it.| STAT
The privatization of medical research can’t replace what the NIH has provided.| STAT
Competitive bidding for catheters means reduced patient choice, jeopardized supply chains, and an incentive to push cheap, poorly made products.| STAT
